Welcome to the 2021 LUPUS CORA Meeting Program Scheduling
The meeting will officially run on Central European Summer Time (CEST), GMT +2
To convert the meeting times to your local time Click Here
No Topic Needed
Session Type
Industry Session
Date
Fri, 08.10.2021
Session Time
16:15 - 16:45
Room
Industry Hall 1
Chair(s)
- Ricard Cervera (Spain)
Session Description
Beyond proteinuria: additional clinical tools to guide management of lupus nephritis — SUPPORTED BY GlaxoSmithKline
Session Description:
A non-promotional symposium, organized by GSK, discussing evidence on how current clinical tools and kidney biopsies can be utilized for effective management of lupus nephritis throughout the patient journey. The opening presentation will introduce diagnostic biopsy as the current gold standard tool. This presentation will be followed by a discussion about various clinical tools to assess response to therapy and therapy-withdrawal decisions. The utility of repeat biopsies at various decision points will be explored.
Beyond proteinuria: additional clinical tools to guide management of lupus nephritis
Lecture Time
16:15 - 16:15
Supported by GlaxoSmithKline
Lecture Time
16:15 - 16:15
Introduction
Presenter
- Ricard Cervera (Spain)
Lecture Time
16:15 - 16:17
Setting the scene: diagnosing lupus nephritis
Presenter
- Ana Malvar (Argentina)
Lecture Time
16:17 - 16:22
Assessing response to induction therapy
Presenter
- Ricard Cervera (Spain)
- Ana Malvar (Argentina)
Lecture Time
16:22 - 16:30
Assessing response to maintenance therapy and therapy-withdrawal
Presenter
- Ricard Cervera (Spain)
- Ana Malvar (Argentina)
Lecture Time
16:30 - 16:38
Closing remarks
Presenter
- Ricard Cervera (Spain)
- Ana Malvar (Argentina)
Lecture Time
16:38 - 16:40
Live attendee Q&A
Lecture Time
16:40 - 16:45